Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors
The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Abstract
Studies in mammalian skin have shown expression of the genes for corticotropin‐releasing hormone (CRH) and the related urocortin peptide, with subsequent production of the respective peptides. Recent molecular and biochemical analyses have further revealed the presence of CRH receptors (CRH‐Rs). These CRH‐Rs are functional, responding to CRH and urocortin peptides (exogenous or produced locally) through activation of receptor(s)‐mediated pathways to modify skin cell phenotype. Thus, when taken together with the previous findings of cutaneous expression of POMC and its receptors, these observations extend the range of regulatory elements of the hypo‐thalamic‐pituitary‐adrenal axis expressed in mammalian skin. Overall, the cutaneous CRH/POMC expression is highly reactive to common stressors such as immune cytokines, ultraviolet radiation, cutaneous pathology, or even the physiological changes associated with the hair cycle phase. Therefore, similar to its central analog, the local expression and action of CRH/POMC elements appear to be highly organized and entrained, representing general mechanism of cutaneous response to stressful stimuli. In such a CRH/ POMC system, the CRH‐Rs may be a central element.—Slominski, A., Wortsman, J., Pisarchik, A., Zbytek, B., Linton, E. A., Mazurkiewicz, J., Wei, E. T. Cutaneous expression of corticotropin‐releasing hormone (CRH), urocortin, and CRH receptors. FASEB J . 15, 1678–1693 (2001)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This stimulation was accompanied by upregulation of the production of corticotropin releasing factor (CRF), urocortin (Unc) and POMC derived peptides”
From The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions (2014) · cites this paper as [35]
Citations
Cites
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., Chan, R., Turnbull, A. V., Lovejoy, D., Rivier, C., et al. (1995) · Nature · doi:10.1038/378287a0 · Cited by 1,479 · cited 1×
“In humans, the final product of the urocortin gene is a peptide 40 amino acids long, with 45% homology to rat/human CRH, and more than 90% homology with rat, mouse, and hamster urocortin peptides (47, 49, 50).”
BackgroundPhysiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,142 · cited 4×
“The cytokines interleukin 1 (IL-1), IL-6, and tumor necrosis factor a stimulate CRH production through the activation of the CRH promoter by transcription factors associated with cytokine signaling (19, 20, 29, 39).”
BackgroundInfluentialExpression cloning of a human corticotropin-releasing-factor receptor.
Chen, R., Lewis, K. A., Perrin, M. H., & Vale, W. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8967 · Cited by 927
Grossman, R. M., Krueger, J., Yourish, D., Granelli-Piperno, A., Murphy, D. P., May, L. T., Kupper, T. S., Sehgal, P. B., & Gottlieb, A. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6367 · Cited by 853 · cited 1×
“medium stimulates keratinocyte proliferation (129),”
Lovenberg, T. W., Liaw, C. W., Grigoriadis, D. E., Clevenger, W., Chalmers, D. T., De Souza, E. B., & Oltersdorf, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.836 · Cited by 846 · cited 1×
“The CRH-R2a and b isoforms have been cloned in the rat, mouse, and tree shrew (2, 11, 75, 76, 85, 86), and the CRH-R2a-tr isoform that contains unspliced introns 6 and 7 and encodes a 236 aa truncated protein has been cloned in rats (87).”
BackgroundSlominski, A., Wortsman, J., Luger, T., Paus, R., & Solomon, S. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.979 · Cited by 776 · cited 9×
“Rodent Epidermal keratinocytes (2) (1) (1) (1) Follicular keratinocytes (2) (1) (1) (1) Malignant melanocytes (NP) (NP) (1) (1) Normal melanocytes (NP) (NP) (1) (NP) Cells of pilosebaceus unit (2) (1) (NP) (NP) Dermal nerves (NA) (1) (NA) (NP) *Fibroblasts (?) (1) (1/?) (1/?) *Endothelial cells (?) (1) (1/?) (1/?) *Re…”
BackgroundMethodInfluentialSelf-citationNeuroendocrinology of the Skin1
Slominski, A., & Wortsman, J. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.5.0410 · Cited by 727
Self-citationIntraadrenal interactions in the regulation of adrenocortical steroidogenesis.
Ehrhart-Bornstein, M., Hinson, J. P., Bornstein, S. R., Scherbaum, W. A., & Vinson, G. P. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0326 · Cited by 600
Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2
Kishimoto, T., Radulovic, J., Radulovic, M., Lin, C. R., Schrick, C., Hooshmand, F., Hermanson, O., Rosenfeld, M. G., & Spiess, J. (2000) · Nature Genetics · doi:10.1038/74271 · Cited by 502 · cited 1×
“Nevertheless, the CRH-R2 knockout mouse has enhanced susceptibility to thermal injury (123).”
BackgroundNeuroendocrinology of the Skin
Slominski, A. (2000) · Endocrine Reviews · doi:10.1210/er.21.5.457 · Cited by 502
Self-citationAutocrine or Paracrine Inflammatory Actions of Corticotropin-Releasing Hormone in Vivo
Karalis, K., Sano, H., Redwine, J., Listwak, S., Wilder, R. L., & Chrousos, G. P. (1991) · Science · doi:10.1126/science.1925600 · Cited by 482 · cited 2×
“Proinflammatory CRH effects have also been suggested based on observations made in other experimental models (10, 25, 65, 100) that include experimental arthritis and uveoretinitis, as well as on studies in transgenic immunodeficient mice (65, 120–122).”
BackgroundTheoharides, T. C., Singh, L. K., Boucher, W. S., Pang, X., Létourneau, R., Webster, E., & Chrousos, G. P. (1998) · Endocrinology · doi:10.1210/en.139.1.403 · Cited by 447
Koylu, E. O., Couceyro, P. R., Lambert, P. D., & Kuhar, M. J. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980202)391:1<115::aid-cne10>3.0.co;2-x · Cited by 446
Corticotropin Releasing Factor Receptors and Their Ligand Family
PERRIN, M. H., & VALE, W. W. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08687.x · Cited by 429 · cited 2×
“intracellular accumulation of cAMP (28, 45, 76, 77).”
BackgroundIsolation and sequence analysis of the human corticotropin-releasing factor precursor gene.
Shibahara, S., Morimoto, Y., Furutani, Y., Notake, M., Takahashi, H., Shimizu, S., Horikawa, S., & Numa, S. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01499.x · Cited by 422
Corticotrophin-releasing factor receptors: from molecular biology to drug design
Chalmers, D. T., Lovenberg, T. W., Grigoriadis, D. E., Behan, D. P., & De Souza, E. B. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)81594-x · Cited by 398
A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle.
Kishimoto, T., Pearse, R. V., Lin, C. R., & Rosenfeld, M. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1108 · Cited by 372 · cited 1×
“The CRH-R2a and b isoforms have been cloned in the rat, mouse, and tree shrew (2, 11, 75, 76, 85, 86), and the CRH-R2a-tr isoform that contains unspliced introns 6 and 7 and encodes a 236 aa truncated protein has been cloned in rats (87).”
BackgroundCloning and characterization of human urocortin.
Donaldson, C. J., Sutton, S. W., Perrin, M. H., Corrigan, A. Z., Lewis, K. A., Rivier, J. E., Vaughan, J. M., & Vale, W. W. (1996) · Endocrinology · doi:10.1210/endo.137.5.8612563 · Cited by 372 · cited 1×
“In humans, the final product of the urocortin gene is a peptide 40 amino acids long, with 45% homology to rat/human CRH, and more than 90% homology with rat, mouse, and hamster urocortin peptides (47, 49, 50).”
BackgroundPeptide Signaling in Human Placenta and Membranes: Autocrine, Paracrine, and Endocrine Mechanisms*
PETRAGLIA, F., FLORIO, P., NAPPI, C., & GENAZZANI, A. R. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-156 · Cited by 352 · cited 4×
“demands the developmentally programmed, tissue-restricted differential expression of CRH receptors in the placenta, decidua, fetal membranes, endometrium, myometrium, and uterine vasculature (13, 23, 26, 33, 34).”
BackgroundInfluentialEvidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta
Petraglia, F., Sawchenko, P. E., Rivier, J., & Vale, W. (1987) · Nature · doi:10.1038/328717a0 · Cited by 337
Chakraborty, A. K., Funasaka, Y., Slominski, A., Ermak, G., Hwang, J., Pawelek, J. M., & Ichihashi, M. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(96)00063-8 · Cited by 333
Self-citationVita, N., Laurent, P., Lefort, S., Chalon, P., Lelias, J.-M., Kaghad, M., Le Fur, G., Caput, D., & Ferrara, P. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80427-v · Cited by 323
Feeding and body-weight regulation by hypothalamic neuropeptides—mediation of the actions of leptin
Inui, A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01292-2 · Cited by 318 · cited 1×
“Leptin can also stimulate CRH gene expression and basal CRH release (40).”
BackgroundCorticotropin-Releasing Hormone in Humans*
ORTH, D. N. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-164 · Cited by 282 · cited 5×
“CRE mediates activation of the CRH promoter by cAMP-dependent PKA and CaMK pathways (19, 20, 28, 29).”
BackgroundInfluentialKostich, W. A., Chen, A., Sperle, K., & Largent, B. L. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.8.0145 · Cited by 256 · cited 1×
“The CRH-R2g variant has been found only in the brain ( 83 ).”
BackgroundDistribution of urocortin-like immunoreactivity in the central nervous system of the rat
Kozicz, T., Yanaihara, H., & Arimura, A. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980202)391:1<1::aid-cne1>3.0.co;2-6 · Cited by 256
Urocortin Protects against Ischemic and Reperfusion Injury via a MAPK-dependent Pathway
Brar, B. K., Jonassen, A. K., Stephanou, A., Santilli, G., Railson, J., Knight, R. A., Yellon, D. M., & Latchman, D. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8508 · Cited by 236 · cited 1×
“corticotropes (104), cardiac myocytes (105), and”
Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart
Stenzel, P. (1995) · Molecular Endocrinology · doi:10.1210/me.9.5.637 · Cited by 235
Liaw, C. W. (1996) · Endocrinology · doi:10.1210/en.137.1.72 · Cited by 235
The role of corticotropin-releasing factor in pain and analgesia
Lariviere, W. R., & Melzack, R. (2000) · Pain · doi:10.1016/s0304-3959(99)00193-1 · Cited by 231
Malkoski, S. P. (1999) · Molecular Endocrinology · doi:10.1210/me.13.10.1629 · Cited by 225 · cited 1×
“The well-known negative regulation of CRH production by glucocorticoids appears to result from direct interaction between the glucocorticoid receptor (GR) and either the GR binding site in the 59-flanking CRH gene region or the CRE binding protein (19, 20, 28, 29, 41 , 42).”
BackgroundRat Corticotropin-Releasing Hormone Gene: Sequence and Tissue-Specific Expression*
Thompson, R. C., Seasholtz, A. F., & Herbert, E. (1987) · Molecular Endocrinology · doi:10.1210/mend-1-5-363 · Cited by 215
Theoharides, T. C., Spanos, C., Pang, X., Alferes, L., Ligris, K., Letourneau, R., Rozniecki, J. J., Webster, E., & Chrousos, G. P. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588332 · Cited by 214
Maillot, C., Million, M., Wei, J. Y., Gauthier, A., & Taché, Y. (2000) · Gastroenterology · doi:10.1053/gast.2000.20251 · Cited by 206
Karalis, K., Muglia, L. J., Bae, D., Hilderbrand, H., & Majzoub, J. A. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00178-6 · Cited by 203
Corticotropin Releasing Hormone, Receptor Regulation and the Stress Response
Aguilera, G. (1998) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(98)00079-4 · Cited by 195 · cited 3×
“The well-known negative regulation of CRH production by glucocorticoids appears to result from direct interaction between the glucocorticoid receptor (GR) and either the GR binding site in the 59-flanking CRH gene region or the CRE binding protein (19, 20, 28, 29, 41, 42).”
BackgroundSingh, L. K., Boucher, W., Pang, X., Letourneau, R., Seretakis, D., Green, M., & Theoharides, T. C. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38092-9 · Cited by 164 · cited 2×
“found that intradermally injected CRH and urocortin induced local mast cell degranulation in rats and mice (100, 119).”
BackgroundUrocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa
Muramatsu, Y., Fukushima, K., Iino, K., Totsune, K., Takahashi, K., Suzuki, T., Hirasawa, G., Takeyama, J., Ito, M., Nose, M., et al. (2000) · Peptides · doi:10.1016/s0196-9781(00)00335-1 · Cited by 164
Slominski, A., Ermak, G., Hwang, J., Chakraborty, A., Mazurkiewicz, J. E., & Mihm, M. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01090-2 · Cited by 160
Self-citationVAMVAKOPOULOS, N. C., & CHROUSOS, G. P. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-4-409 · Cited by 159 · cited 1×
“Proinflammatory CRH effects have also been suggested based on observations made in other experimental models (10, 25, 65, 100) that include experimental arthritis and uveoretinitis, as well as on studies in transgenic immunodeficient mice (65, 120–122).”
BackgroundUrocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart
Nishikimi, T., Miyata, A., Horio, T., Yoshihara, F., Nagaya, N., Takishita, S., Yutani, C., Matsuo, H., Matsuoka, H., & Kangawa, K. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.6.h3031 · Cited by 157
Cutaneous Expression of CRH and CRH‐R: Is There a “Skin Stress Response System?”
SLOMINSKI, A. T., BOTCHKAREV, V., CHOUDHRY, M., FAZAL, N., FECHNER, K., FURKERT, J., KRAUSE, E., ROLOFF, B., SAYEED, M., WEI, E., et al. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08686.x · Cited by 147
Self-citationRole of corticotropin-releasing hormone in onset of labour
Grammatopoulos, D. K., & Hillhouse, E. W. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03418-2 · Cited by 147 · cited 4×
“demands the developmentally programmed, tissue-restricted differential expression of CRH receptors in the placenta, decidua, fetal membranes, endometrium, myometrium, and uterine vasculature (13, 23, 26, 33, 34).”
BackgroundInfluentialHuman placenta and fetal membranes express human urocortin mRNA and peptide
Petraglia, F. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3807 · Cited by 146 · cited 1×
“Nevertheless, it is apparent that the skin represents a new extracranial source of urocortin with proven manufacturing capability similar to the human placenta, amnion, chorion, decidua, the gastrointestinal system, and lymphocytes (7, 16, 17, 22, 34, 72) and to rodent cardiac myocytes, digestive system, pancreas, pit…”
BackgroundArai, M., Assil, I. Q., & Abou-Samra, A. B. (2001) · Endocrinology · doi:10.1210/endo.142.1.7879 · Cited by 142
Expression and protective effects of urocortin in cardiac myocytes
Okosi, A., Brar, B. K., Chan, M., D'Souza, L., Smith, E., Stephanou, A., Latchman, D. S., Chowdrey, H. S., & Knight, R. A. (1998) · Neuropeptides · doi:10.1016/s0143-4179(98)90033-6 · Cited by 137 · cited 1×
“Nevertheless, it is apparent that the skin represents a new extracranial source of urocortin with proven manufacturing capability similar to the human placenta, amnion, chorion, decidua, the gastrointestinal system, and lymphocytes (7, 16, 17, 22, 34, 72) and to rodent cardiac myocytes, digestive system, pancreas, pit…”
BackgroundHuman Lymphocytes Produce Urocortin, But Not Corticotropin-Releasing Hormone
Bamberger, C. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.708 · Cited by 133 · cited 1×
“Nevertheless, it is apparent that the skin represents a new extracranial source of urocortin with proven manufacturing capability similar to the human placenta, amnion, chorion, decidua, the gastrointestinal system, and lymphocytes (7, 16, 17, 22, 34, 72) and to rodent cardiac myocytes, digestive system, pancreas, pit…”
BackgroundGrammatopoulos, D. K., Dai, Y., Randeva, H., Levine, M. A., Karteris, E., Easton, A. J., & Hillhouse, E. W. (1999) · Molecular Endocrinology · doi:10.1210/me.13.12.2189 · Cited by 124
Kageyama, K., Bradbury, M. J., Zhao, L., Blount, A. L., & Vale, W. W. (1999) · Endocrinology · doi:10.1210/endo.140.12.7223 · Cited by 123
Grammatopoulos, D. K., Randeva, H. S., Levine, M. A., Katsanou, E. S., & Hillhouse, E. W. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.12.0574 · Cited by 117
Potential mechanism of skin response to stress
SLOMINSKI, A., & MIHM, M. C. (1996) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1996.tb05049.x · Cited by 115
Self-citationA new functional isoform of the human CRF2 receptor for corticotropin-releasing factor
Valdenaire, O., Giller, T., Breu, V., Gottowik, J., & Kilpatrick, G. J. (1997) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(97)00047-x · Cited by 115 · cited 1×
“Y10152 and Y10153 (84) have also been described.”
BackgroundKostich, W. A. (1998) · Molecular Endocrinology · doi:10.1210/me.12.8.1077 · Cited by 114
Corticotropin-releasing factor in antinociception and inflammation
Schäfer, M., Mousa, S. A., & Stein, C. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00057-5 · Cited by 109
Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms
Petraglia, F. (1996) · Endocrine Reviews · doi:10.1210/er.17.2.156 · Cited by 100
Characterization of Corticotropin-Releasing Hormone (CRH) in Human Skin1
Slominski, A., Ermak, G., Mazurkiewicz, J. E., Baker, J., & Wortsman, J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4650 · Cited by 99
Self-citationThe Structures of the Mouse and Human Urocortin Genes (Ucn and UCN)
Zhao, L., Donaldson, C. J., Smith, G. W., & Vale, W. (1998) · Genomics · doi:10.1006/geno.1998.5292 · Cited by 95
Slominski, A. T. (1996) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(95)00159-x · Cited by 93 · cited 5×
“Molecular analyses have demonstrated the expression of both CRH-R1 and CRH-R2 genes in rodent skin (1, 4, 57, 58).”
BackgroundResultInfluentialSelf-citationRoloff, B., Fechner, K., Slominski, A., Furkert, J., Botchkarev, V. A., Bulfone‐Paus, S., Zipper, J., Krause, E., & Paus, R. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.03.287 · Cited by 91
Self-citationRossant, C. J., Pinnock, R. D., Hughes, J., Hall, M. D., & McNulty, S. (1999) · Endocrinology · doi:10.1210/endo.140.4.6656 · Cited by 88
Kuryshev, Y. A. (1996) · Endocrinology · doi:10.1210/en.137.6.2269 · Cited by 86
Urocortin Expression in Human Pituitary Gland and Pituitary Adenoma
Iino, K., Sasano, H., Oki, Y., Andoh, N., Shin, R.-W., Kitamoto, T., Totsune, K., Takahashi, K., Suzuki, H., Nagura, H., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4371 · Cited by 84 · cited 1×
“Urocortin has also been detected in the anterior pituitary gland (54, 55) and peripherally in a variety of human and rat tissues that include placenta, uterus, immune system, stomach, small and large bowel, pancreas, adrenal gland, testis, and heart (7, 16–18, 22, 56).”
BackgroundTakahashi, K., Totsune, K., Sone, M., Murakami, O., Satoh, F., Arihara, Z., Sasano, H., Iino, K., & Mouri, T. (1998) · Peptides · doi:10.1016/s0196-9781(98)00012-6 · Cited by 83 · cited 1×
“Urocortin has also been detected in the anterior pituitary gland (54, 55) and peripherally in a variety of human and rat tissues that include placenta, uterus, immune system, stomach, small and large bowel, pancreas, adrenal gland, testis, and heart (7, 16–18, 22, 56).”
BackgroundPetraglia, F. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.4.1420 · Cited by 82 · cited 1×
“They are thought to be involved in maintaining quiescence throughout pregnancy and in the initiation and progression of labor, being activated by circulating placental CRH and by locally produced CRH or urocortin through paracrine or autocrine mechanisms (13, 34, 46 , 109).”
BackgroundSchilling, L., Kanzler, C., Schmiedek, P., & Ehrenreich, H. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702182 · Cited by 81
Ross, P. C., Kostas, C. M., & Ramabhadran, T. V. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2884 · Cited by 81
Presence of immunoreactive corticotropin-releasing hormone in human endometrium
Mastorakos, G. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.1046 · Cited by 79 · cited 1×
“When peripheral processing of proCRH into CRH has been evaluated, it appears to be similar to that at the central level, at least in placenta, endometrium, uterus, and the immune system (13, 15, 34, 64, 65).”
BackgroundUltraviolet B stimulates production of corticotropin releasing factor (CRF) by human melanocytes
Slominski, A., Baker, J., Ermak, G., Chakraborty, A., & Pawelek, J. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01315-4 · Cited by 78
Self-citationOki, Y., Iwabuchi, M., Masuzawa, M., Watanabe, F., Ozawa, M., Iino, K., Tominaga, T., & Yoshimi, T. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)01182-x · Cited by 77
Slominski, A., Roloff, B., Curry, J., Dahiya, M., Szczesniewski, A., & Wortsman, J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6381 · Cited by 77
Self-citationRadulovic, M., Dautzenberg, F. M., Sydow, S., Radulovic, J., & Spiess, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.3013 · Cited by 74 · cited 1×
“variably shows CRH to be immunoinhibitory (71).”
Arai, M. (2001) · Endocrinology · doi:10.1210/en.142.1.446 · Cited by 73 · cited 1×
“Very recent work by Arai and colleagues has identified a third CRH receptor subtype in catfish that originates from a third gene, distinct from R1 and R2 receptor genes (88).”
BackgroundActions of CRF and its Analogs
Eckart, K., Radulovic, J., Radulovic, M., Jahn, O., Blank, T., Stiedl, O., & Spiess, J. (1999) · Current Medicinal Chemistry · doi:10.2174/092986730611220401163925 · Cited by 72
Funasaka, Y., Sato, H., Chakraborty, A. K., Ohashi, A., Chrousos, G. P., & Ichihashi, M. (1999) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsp.5640192 · Cited by 71 · cited 3×
“2; 59–61); CRH gene expression has also been detected by others in established melanoma cell lines, cultured junctional and dermal nevocytes, epidermal melanocytes, epidermis, and hair follicles (62, 63).”
BackgroundKAVELAARS, A., BERKENBOSCH, F., CROISET, G., BALLIEUX, R. E., & HEIJNEN, C. J. (1990) · Endocrinology · doi:10.1210/endo-126-2-759 · Cited by 70
Characterization of Corticotropin-Releasing Hormone (CRH) in Human Skin
Slominski, A. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.1020 · Cited by 70
Self-citationKarteris, E., Grammatopoulos, D., Dai, Y., Olah, K. B., Ghobara, T. B., Easton, A., & Hillhouse, E. W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4705 · Cited by 69
Yamamoto, H., Maeda, T., Fujimura, M., & Fujimiya, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00071-8 · Cited by 68
Palchaudhuri, Hauger, Wille, Fuchs, & Dautzenberg§ (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00348.x · Cited by 67 · cited 1×
“The CRH-R2a and b isoforms have been cloned in the rat, mouse, and tree shrew (2, 11, 75, 76, 85, 86), and the CRH-R2a-tr isoform that contains unspliced introns 6 and 7 and encodes a 236 aa truncated protein has been cloned in rats (87).”
BackgroundGrammatopoulos, D., Dai, Y., Chen, J., Karteris, E., Papadopoulou, N., Easton, A. J., & Hillhouse, E. W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4985 · Cited by 66 · cited 1×
“of CRH receptors have been identified (96).”
Lee, A. K., & Tse, A. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.367be.x · Cited by 65
Corticotropin-releasing hormone deficiency unmasks the proinflammatory effect of epinephrine
Karalis, K. P., Kontopoulos, E., Muglia, L. J., & Majzoub, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7093 · Cited by 64
Slominski, A. T. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.815 · Cited by 63 · cited 5×
“These studies have clearly shown expression of the urocortin gene and accumulation of the corresponding peptide in human skin cells (5).”
BackgroundMethodInfluentialSelf-citationITOI, K., SEASHOLTZ, A. F., & WATSON, S. J. (1998) · Endocrine Journal · doi:10.1507/endocrj.45.13 · Cited by 62
Slominski, A., Szczesniewski, A., & Wortsman, J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6863 · Cited by 58
Self-citationPaez Pereda, M., Sauer, J., Perez Castro, C., Finkielman, S., Stalla, G. K., Holsboer, F., & Arzt, E. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588301 · Cited by 58
Mastorakos, G. (1995) · Endocrinology · doi:10.1210/en.136.10.4650 · Cited by 57
Corticotropin-Releasing Hormone Stimulates Angiogenesis and Epithelial Tumor Growth in the Skin
Arbiser, J. L., Karalis, K. P., Viswanathan, A. N., Koike, C., Anand‐Apte, B., Flynn, E. A., Zetter, B. R., & Majzoub, J. A. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00760.x · Cited by 57 · cited 3×
“Local administration of CRH also inhibits the response to nociceptive stimuli (24), enhances wound healing (110), and may affect angiogenesis (116).”
BackgroundInhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs.
Carlson, K. W., Nawy, S. S., Wei, E. T., Sadée, W., Filov, V. A., Rezsova, V. V., Slominski, A. T., & Quillan, J. M. (2001) · PubMed · Cited by 57
Self-citationSlominski, A. T., Roloff, B., Zbytek, B., Wei, E. T., Fechner, K., Curry, J. L., & Wortsman, J. (2000) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/1071-2690(2000)036<0201:ahsemt>2.0.co;2 · Cited by 56
Self-citationThe Genomic Structure of the Rat Corticotropin Releasing Factor Receptor
Tsai-Morris, C. H., Buczko, E., Geng, Y., Gamboa-Pinto, A., & Dufau, M. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14519 · Cited by 55
Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells
Fazal, N., Slominski, A., Choudhry, M. A., Wei, E. T., & Sayeed, M. M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01067-9 · Cited by 54
Self-citationMazurkiewicz, J. E., Corliss, D., & Slominski, A. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800703 · Cited by 53 · cited 1×
“It should be emphasized that the same cutaneous compartments coexpress CRH peptide, CRH-R1, and POMC in mouse (136) and human skin (1, 4, 63).”
BackgroundSelf-citationMiyata, I., Shiota, C., Ikeda, Y., Oshida, Y., Chaki, S., Okuyama, S., & Inagami, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0392 · Cited by 53
Nucleotide sequence and expression of the mouse corticotropin-releasing hormone gene
Seasholtz, A. F., Bourbonais, F., Harnden, C. E., & Camper, S. A. (1991) · Molecular and Cellular Neuroscience · doi:10.1016/1044-7431(91)90054-r · Cited by 52
Kageyama, K. (1999) · Endocrinology · doi:10.1210/en.140.12.5651 · Cited by 51 · cited 1×
“Nevertheless, it is apparent that the skin represents a new extracranial source of urocortin with proven manufacturing capability similar to the human placenta, amnion, chorion, decidua, the gastrointestinal system, and lymphocytes (7, 16, 17, 22, 34, 72) and to rodent cardiac myocytes, digestive system, pancreas, pit…”
BackgroundMolecular Properties of the CRF Receptor
Spiess, J., Dautzenberg, F. M., Sydow, S., Hauger, R. L., Rühmann, A., Blank, T., & Radulović, J. (1998) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00037-x · Cited by 50 · cited 1×
“intracellular accumulation of cAMP (28, 45, 76, 77).”
BackgroundSlominski, A. T. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3582 · Cited by 49
Self-citationvan Wijk, P. A., van Neck, J. W., Rijnberk, A., CROUGHS, R. J. M., & Mol, J. A. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03541-e · Cited by 47 · cited 2×
“CRH has been shown to have growth inhibitory effects in the AT-t20 pituitary cell line (1, 43, 44) and in mammary cancer cells (126).”
BackgroundCorticotropin-releasing hormone stimulates steroidogenesis in cultured human adrenal cells
Parker, C. R., Stankovic, A. M., & Goland, R. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00118-5 · Cited by 45
Myers, D. A., Trinh, J. V., & Myers, T. R. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00157-9 · Cited by 44 · cited 1×
“been cloned in the mouse, sheep, and cow (78, 82), but”
BackgroundThe genomic organization of the human corticotropin-releasing factor type-1 receptor
Sakai, K., Yamada, M., HORIBA, N., Wakui, M., Demura, H., & Suda, T. (1998) · Gene · doi:10.1016/s0378-1119(98)00322-9 · Cited by 43
Emanuel, R. L., Torday, J. S., Asokananthan, N., & Sunday, M. E. (2000) · Peptides · doi:10.1016/s0196-9781(00)00343-0 · Cited by 43
Expression of corticotrophin-releasing hormone receptor mRNA and protein in the human myometrium
Rodriguez-Linares, B., Linton, E., & Phaneuf, S. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560015 · Cited by 41
Self-citationGrammatopoulos, D. K. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.7.2539 · Cited by 41
Corticotrophin Releasing Hormone: Its Potential for a Role in Human Myometrium
Linton, E. A., Woodman, J., Asbóth, G., Glynn, B. P., Plested, C. P., & Bernal, A. L. (2001) · Experimental Physiology · doi:10.1113/eph8602183 · Cited by 40 · cited 7×
“When peripheral processing of proCRH into CRH has been evaluated, it appears to be similar to that at the central level, at least in placenta, endometrium, uterus, and the immune system (13, 15, 34, 64, 65).”
BackgroundInfluentialSelf-citationGrammatopoulos, D. K. (2000) · Molecular Endocrinology · doi:10.1210/me.14.12.2076 · Cited by 38
Paracrine regulation of human placenta: control of hormonogenesis
Petraglia, F., Santuz, M., Florio, P., Simoncini, T., Luisi, S. V., Plaino, L., Genazzani, A. R., Genazzani, A. D., & Volpe, A. (1998) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(98)00024-2 · Cited by 37 · cited 4×
“demands the developmentally programmed, tissue-restricted differential expression of CRH receptors in the placenta, decidua, fetal membranes, endometrium, myometrium, and uterine vasculature (13, 23, 26, 33, 34).”
BackgroundInfluentialRohde, E., Furkert, J., Fechner, K., Beyermann, M., Mulvany, M. J., Richter, R. M., Denef, C., Bienert, M., & Berger, H. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00300-0 · Cited by 37
Ramkumar, T. P., & Adler, S. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.8.0327 · Cited by 36 · cited 1×
“The well-known negative regulation of CRH production by glucocorticoids appears to result from direct interaction between the glucocorticoid receptor (GR) and either the GR binding site in the 59-flanking CRH gene region or the CRE binding protein (19, 20, 28, 29, 41, 42).”
BackgroundHeinrich, N. (1998) · Endocrinology · doi:10.1210/en.139.2.651 · Cited by 36
Kravchenco, I. V., & Furalyov, V. A. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2534 · Cited by 36
Tjuvajev, J., Kolesnikov, Y. A., Joshi, R., Sherinski, J., Koutcher, L. D., Zhou, Y., Matei, C., Koutcher, J. A., Kreek, M. J., & Blasberg, R. (1998) · PubMed · Cited by 34
Urocortin and Inflammation: Confounding Effects of Hypotension on Measures of Inflammation
Torpy, D. J., Webster, E. L., Zachman, E. K., Aguilera, G., & Chrousos, G. P. (1999) · NeuroImmunoModulation · doi:10.1159/000026380 · Cited by 34 · cited 1×
“More recently, it was found that urocortin is significantly more potent than CRH at inhibiting heat-induced cutaneous edema in rats (70, 113).”
BackgroundSUPPRESSION OF ANTIGEN-SPECIFIC LYMPHOCYTE ACTIVATION IN MODELED MICROGRAVITY
COOPER, D., Pride, M. W., Brown, E. L., Risin, D., & Pellis, N. R. (2001) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/1071-2690(2001)037<0063:soasla>2.0.co;2 · Cited by 33
Self-citationDirect shoot organogenesis and plant regeneration in safflower
Mandal, A. K. A., & Gupta, S. D. (2001) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/s11627-001-0010-5 · Cited by 31
Local Expression of Corticotropin‐Releasing Hormone in Inflammatory Arthritis
Crofford, L. J., Sano, H., Karalis, K. P., WEBSTER, E. A., Friedman, T. C., Chrousos, G. P., & Wilder, R. L. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44702.x · Cited by 30 · cited 1×
“(116) have suggested that CRH is a stimulator of angiogenesis and others showed that anti-CRH antibodies can decrease inflammation in vivo (65, 120).”
BackgroundLi, H., Robinson, P. J., Kawashima, S., Funder, J. W., & Liu, J. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00093-4 · Cited by 29 · cited 1×
“corticotropes (104), cardiac myocytes (105), and”
Zoumakis, E., Margioris, A. N., Makrigiannakis, A., Stournaras, C., & Gravanis, A. (1997) · Journal of Endocrinological Investigation · doi:10.1007/bf03346896 · Cited by 29 · cited 2×
“demands the developmentally programmed, tissue-restricted differential expression of CRH receptors in the placenta, decidua, fetal membranes, endometrium, myometrium, and uterine vasculature (13, 23, 26, 33, 34).”
BackgroundMcLoon, L. K., & Wirtschafter, J. D. (1997) · PubMed · Cited by 28
Gao, G. C., Dashwood, M. R., & Wei, E. T. (1991) · Peptides · doi:10.1016/0196-9781(91)90113-4 · Cited by 28 · cited 2×
“CRH binding sites were also found on blood vessels and epithelial cells of the rat skin (66).”
BackgroundSelf-citationWei, E. T., Thomas, H. A., Christian, H., Buckingham, J. C., & Kishimoto, T. (1998) · Peptides · doi:10.1016/s0196-9781(98)00085-0 · Cited by 28
Self-citationC/EBP activates the human corticotropin-releasing hormone gene promoter
Stephanou, A., Okosi, A., Knight, R. A., Chowdrey, H. S., & Latchman, D. S. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00170-6 · Cited by 27 · cited 1×
“The cytokines interleukin 1 (IL-1), IL-6, and tumor necrosis factor a stimulate CRH production through the activation of the CRH promoter by transcription factors associated with cytokine signaling (19, 20, 29, 39).”
BackgroundFleisher‐Berkovich, S., & Danon, A. (1995) · Endocrinology · doi:10.1210/endo.136.9.7649115 · Cited by 26
Kiang, J. G. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90164-3 · Cited by 25
Rossant, C. J. (1999) · Endocrinology · doi:10.1210/en.140.4.1525 · Cited by 24
Karteris, E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.4.1376 · Cited by 22
Perone, M. J., Murray, C. A., Brown, O. A., Gibson, S., White, A. E., Linton, E. A., Perkins, A. V., Lowenstein, P. R., & Castro, M. G. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00104-x · Cited by 21
Self-citationGjerde, E.-A. B., Woie, K., Wei, E. T., & Reed, R. K. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00403-8 · Cited by 20 · cited 2×
“The anti-edema CRH action has been interpreted as arising from a ligand-induced inhibition of the negative interstitial fluid pressure generated in the extracellular matrix of traumatized tissues (112).”
BackgroundSelf-citationRobinson, B. M., Tellam, D. J., Smart, D., Mohammad, Y. N., Brennand, J. C., Rivier, J., & Lovejoy, D. A. (1999) · Peptides · doi:10.1016/s0196-9781(99)00121-7 · Cited by 20
Borrelli, E. (1998) · Nature Genetics · doi:10.1038/452 · Cited by 18 · cited 1×
“CRH is the most proximal neuroendocrine element in the activation of the HPA axis; as such, it coordinates the complex array of behavioral, autonomic, and endocrine responses to stress (135).”
BackgroundDm, B., & Corder, R. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702261 · Cited by 18 · cited 1×
“Although dermal endothelial cells were not tested, expression of CRH receptors at this site is likely since endothelial cells of noncutaneous origin do express them (95, 99).”
BackgroundAnti-inflammatory activity of corticotropin releasing factor: II. Mechanisms of action.
Jg, K., Poree, L. R., & Et, W. (1987) · PubMed · Cited by 18
Ahmed, I. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.755 · Cited by 18
Wei, E. T., & Thomas, H. A. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90729-3 · Cited by 17 · cited 1×
“Earlier studies performed on animal models of tissue injury (24, 67, 70, 110, 111) revealed that peptides of the CRH superfamily have anti-inflammatory effects (70).”
BackgroundSelf-citationGrammatopoulos, D. K., & Hillhouse, E. W. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00238-4 · Cited by 16
Brar, B. K., Sanderson, T. C., Wang, N., & Lowry, P. J. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1540431 · Cited by 15 · cited 1×
“Pro-CRH undergoes endoproteolytic processing within the trans-Golgi network and secretory granules that appears to be controlled by the convertases PC1 and PC2 to generate the final 41 aa residue (4.7 kDa) CRH peptide (29, 37, 38 ).”
BackgroundInfluentialGenomic organization and tissue-specific expression of rat urocortin
Park, J., Lee, Y.-J., Na, S.-Y., & Kim, K. L. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01434-8 · Cited by 14
Corticotropin releasing factor inhibits proliferation ofAtT-20 cells
Melzig, M. F. (1994) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02631294 · Cited by 13
Fleisher‐Berkovich, S., Rimon, G., & Danon, A. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00107-4 · Cited by 11 · cited 1×
“CRH receptors were also detected in dermal fibroblasts, where two binding sites with different affinities were identified (131).”
BackgroundNavarra, P., Miceli, F., Tringali, G., Minici, F., Pardo, M. G., Lanzone, A., Mancuso, S., & Apa, R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7091 · Cited by 11 · cited 1×
“CRH production in peripheral tissue is enhanced by prostaglandins, CO, EGF, and PDGF and its release is decreased by NO and progesterone (23, 26, 27, 33, 34).”
BackgroundNavarra, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.317 · Cited by 11
IL-1α BUT NOT IL-1β-INDUCED PROSTAGLANDIN SYNTHESIS IS INHIBITED BY CORTICOTROPIN-RELEASING FACTOR
Fleisher‐Berkovich, S., & Danon, A. (1999) · Cytokine · doi:10.1006/cyto.1998.0417 · Cited by 9
Kiang, J. G. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)90131-0 · Cited by 8
Rapid communication: molecular cloning of the porcine corticotropin-releasing factor gene.
Mimmack, M. L., Parrott, R. F., & Vellucci, S. V. (1998) · Journal of Animal Science · doi:10.2527/1998.7682205x · Cited by 5
Research works printed but not linked: 11
- 10.1210/endo.137.1.8536644 · doi:10.1210/endo.137.1.8536644 · Paper page
- Kono M., 2000, Proceedings of the XIth International Congress of Histochemistry and Cytochemistry; Cell Biology and Imaging Tools for New Century, 32
- Wei E. T., 1993, Ciba Foundation Symposium, Vol. 172: Corticotropin-Releasing Factor, 258
- 10.1210/mend.13.12.0391 · doi:10.1210/mend.13.12.0391 · Paper page
- 10.1210/endo.139.1.5660 · doi:10.1210/endo.139.1.5660 · Paper page
- Joyner W. L., 1990, Inhibition of the bradykinin induced inflammation by corticotropin-releasing factor (CRF), FASEB J., 4, 1123
- Joyner W. L., 1989, Mechanism for the anti-inflammatory effect of corticotropin-releasing factor (CRF), FASEB J., 3, A272
- Zbytek B., 2000, Corticotropin-releasing hormone modifies IL-6 and TNF-alpha production by human transformed HaCaT keratinocytes and human SK-MEL188 melanoma cells, Immunol. Lett., 73, 273
- Quevedo M. A., 2001, Pleiotropic effects of corticotropin releasing hormone (CRH) on normal human keratinocytes, In Vitro Cell Dev. Biol., 37, 50, 10.1290/1071-2690(2001)037<0050:PEOCRH>2.0.CO;2 · doi:10.1290/1071-2690(2001)037
- 10.1290/1071-2690(2000)036<0211:CRHARP>2.0.CO;2 · doi:10.1290/1071-2690(2000)036
- Stair-Nawy S., 2000, Modulation of hyaluronon production by mystixin peptides and its role in inflammation
Cited by
D'Orazio, J., Jarrett, S., Amaro-Ortiz, A., & Scott, T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140612222 · Cited by 1,984
“Adaptive melanization is likely a complex physiologic response [4,10,83,85] involving multiple skin”
BackgroundTheoharides, T. C., Alysandratos, K.-D., Angelidou, A., Delivanis, D.-A., Sismanopoulos, N., Zhang, B., Asadi, S., Vasiadi, M., Weng, Z., Miniati, A., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.014 · Cited by 680
“CRH and CRHR mRNA is expressed in human and rodent skin [186,187] and CRH can be secreted from dorsal root ganglia and from sympathetic ganglia [188,189].”
Neuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ
Roosterman, D., Goerge, T., Schneider, S. W., Bunnett, N. W., & Steinhoff, M. (2006) · Physiological Reviews · doi:10.1152/physrev.00026.2005 · Cited by 665
Maternal and Fetal Hypothalamic‐Pituitary‐Adrenal Axes During Pregnancy and Postpartum
MASTORAKOS, G., & ILIAS, I. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.016 · Cited by 621
The CRF peptide family and their receptors: yet more partners discovered
Dautzenberg, F. M., & Hauger, R. L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)01946-6 · Cited by 532
Metadata
- Authors
- SLOMINSKI, A., WORTSMAN, J., PISARCHIK, A., ZBYTEK, B., LINTON, E. A., MAZURKIEWICZ, J. E., & WEI, E. T.
- Affiliations
- University of Tennessee Health Science Center (US)
- SIU Medicine (US)
- Gdańsk Medical University (PL)
- John Radcliffe Hospital (GB)
- Albany Medical College (US)
- University of California, Berkeley (US)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-08
- Volume
- 15
- Issue
- 10
- Pages
- 1678-1693
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1973355249
- Cited by
- 305
- References
- 145
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 7 · 2023: 9 · 2022: 15 · 2021: 5 · 2020: 9 · 2019: 4 · 2018: 7 · 2017: 8 · 2016: 14 · 2015: 7 · 2014: 12 · 2013: 17 · 2012: 23
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- corticotropin-releasing factor, urocortin, CRH receptors, proopiomelanocortin, skin, hypothalamic-pituitary-adrenal axis, stress response, ultraviolet radiation, immune cytokines, hair cycle
- MeSH terms
- Animals, Corticotropin-Releasing Hormone, RNA, Messenger, Rodentia, Skin, Gene Expression, Receptors, Corticotropin-Releasing Hormone, Urocortins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.